Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 11.48%873.61M | 9.88%279.31M | 2.18%227.39M | 29.36%256.34M | 1.70%110.56M | 0.26%783.61M | 3.96%254.19M | -0.86%222.55M | -5.90%198.16M | 6.54%108.71M |
Net income from continuing operations | -26.95%362.94M | -100.65%-976K | 5.27%147.82M | 5.12%137.59M | 3.02%78.5M | 13.27%496.84M | 125.90%149.33M | -3.94%140.43M | -2.47%130.89M | -17.31%76.2M |
Operating gains losses | -20.17%-10.88M | -37.56%-3.58M | -231.24%-4.85M | 61.04%-828K | 43.16%-1.63M | 54.81%-9.06M | 83.10%-2.6M | 8.96%-1.46M | -22.90%-2.13M | -118.95%-2.87M |
Depreciation and amortization | 57.78%462.97M | 233.93%235.44M | 0.64%75.11M | 2.70%77.19M | 2.88%75.23M | -16.03%293.42M | -52.12%70.5M | 13.37%74.64M | 10.93%75.16M | 6.55%73.13M |
Deferred tax | -269.30%-4.04M | -146.07%-679K | -362.39%-3.29M | -138.41%-310K | 121.35%246K | -25.78%2.38M | 8.30%1.47M | 96.40%1.26M | -48.07%807K | -236.84%-1.15M |
Other non cash items | -3.15%6.33M | -7.17%1.5M | -4.12%1.56M | -0.73%1.64M | -0.67%1.63M | 6.17%6.54M | -0.80%1.62M | 3.11%1.63M | 11.70%1.65M | 11.62%1.64M |
Change In working capital | 107.15%2.99M | 57.38%36.92M | -379.09%-4.31M | 270.23%28.57M | -22.07%-58.19M | -49.82%-41.9M | -25.80%23.46M | -117.17%-899K | -271.62%-16.79M | 20.94%-47.67M |
-Change in receivables | -49.60%-43M | 138.14%11.93M | -506.37%-35.9M | 68.17%-21.26M | -90.79%2.23M | -27.69%-28.74M | -28.40%5.01M | 32.98%8.83M | -32.15%-66.8M | 68.18%24.21M |
-Change in prepaid assets | -344.34%-2.66M | -147.12%-1.03M | 15.66%5.04M | -98.49%81K | 37.73%-6.75M | 219.98%1.09M | 23.04%2.18M | 53.81%4.36M | 22,316.67%5.38M | -95.65%-10.83M |
-Change in payables and accrued expense | 1,199.95%22.16M | 133.90%17.46M | -4.88%8.5M | 116.28%16.24M | 22.73%-20.03M | 79.00%-2.02M | 83.35%7.46M | 270.24%8.93M | -5.14%7.51M | -8.02%-25.92M |
-Change in other current assets | -120.76%-7.42M | -310.75%-4.63M | 291.80%7.88M | -233.66%-4.38M | 16.18%-6.31M | -224.05%-3.36M | -40.93%-1.13M | -66.97%2.01M | -42.40%3.27M | 8.98%-7.52M |
-Change in other current liabilities | 482.56%33.91M | 32.81%13.18M | 140.64%10.17M | 11.95%37.89M | 0.96%-27.34M | -479.45%-8.86M | -49.28%9.93M | -96.48%-25.04M | 4.45%33.85M | 25.19%-27.6M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 11.48%873.61M | 9.88%279.31M | 2.18%227.39M | 29.36%256.34M | 1.70%110.56M | 0.26%783.61M | 3.96%254.19M | -0.86%222.55M | -5.90%198.16M | 6.54%108.71M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 46.82%-164.91M | 11.42%-56.86M | 72.92%-31.39M | 59.09%-31.65M | 14.52%-45.02M | 49.91%-310.12M | 70.36%-64.19M | -23.20%-115.92M | 65.63%-77.35M | 36.81%-52.66M |
Capital expenditure reported | 29.72%-125.28M | 6.73%-43.01M | 23.00%-30.14M | 55.35%-22.65M | 30.28%-29.48M | -6.70%-178.27M | 8.26%-46.12M | 4.54%-39.15M | -7.82%-50.72M | -47.03%-42.29M |
Net business purchase and sale | 67.33%-45.39M | 23.22%-14.31M | 96.30%-2.89M | 65.16%-9.93M | -34.04%-18.27M | 71.04%-138.96M | 90.29%-18.64M | -45.99%-78.2M | 84.08%-28.5M | 75.35%-13.63M |
Net other investing changes | -18.87%5.77M | -17.44%464K | 15.02%1.65M | -50.32%930K | -15.92%2.73M | -74.39%7.11M | -97.80%562K | 193.24%1.43M | 86.08%1.87M | 357.46%3.25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 46.82%-164.91M | 11.42%-56.86M | 72.92%-31.39M | 59.09%-31.65M | 14.52%-45.02M | 49.91%-310.12M | 70.36%-64.19M | -23.20%-115.92M | 65.63%-77.35M | 36.81%-52.66M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -46.05%-703.43M | -9.36%-202.2M | -112.67%-244.48M | -71.74%-183.12M | 2.03%-73.63M | -130.10%-481.64M | -239.41%-184.9M | 19.36%-114.96M | -1,014.16%-106.63M | -2,670.18%-75.16M |
Net issuance payments of debt | -691.42%-137.73M | 42.05%-36.24M | -7,854.29%-105.63M | -489.44%-68.43M | 4.30%72.57M | -89.33%23.29M | -419.44%-62.53M | -103.36%-1.33M | -60.58%17.57M | -39.28%69.57M |
Net common stock issuance | 61.23%15.64M | -28.18%3.8M | 112.94%5.68M | 27.35%4.44M | 199.25%1.73M | 15.64%9.7M | 47.18%5.29M | -63.68%2.67M | 16.01%3.49M | 68.66%-1.74M |
Cash dividends paid | -13.43%-579.21M | -32.52%-169.31M | -12.46%-143.58M | -4.37%-133.21M | -4.37%-133.12M | -0.39%-510.62M | 16.40%-127.76M | -4.49%-127.67M | -4.70%-127.63M | -14.20%-127.55M |
Net other financing activities | 47.12%-2.12M | -533.96%-460K | -108.26%-940K | 26,671.70%14.08M | 4.13%-14.8M | -105.52%-4.01M | -99.86%106K | 116.91%11.38M | -100.08%-53K | -33,463.04%-15.44M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -46.05%-703.43M | -9.36%-202.2M | -112.67%-244.48M | -71.74%-183.12M | 2.03%-73.63M | -130.10%-481.64M | -239.41%-184.9M | 19.36%-114.96M | -1,014.16%-106.63M | -2,670.18%-75.16M |
Net cash flow | ||||||||||
Beginning cash position | -15.23%44.61M | -25.09%29.51M | 63.11%77.93M | 8.60%36.41M | -15.23%44.61M | -47.27%52.62M | -50.36%39.4M | -47.89%47.78M | -71.07%33.52M | -47.27%52.62M |
Current changes in cash | 164.84%5.28M | 297.06%20.25M | -482.22%-48.47M | 193.00%41.58M | 57.71%-8.08M | 82.60%-8.14M | 119.19%5.1M | 31.59%-8.33M | 159.09%14.19M | -219.55%-19.11M |
Effect of exchange rate changes | -433.07%-423K | -371.82%-299K | 181.36%48K | -178.79%-52K | -1,300.00%-120K | 132.48%127K | 169.18%110K | 63.35%-59K | 137.08%66K | -90.65%10K |
End cash Position | 10.89%49.46M | 10.89%49.46M | -25.09%29.51M | 63.11%77.93M | 8.60%36.41M | -15.23%44.61M | -15.23%44.61M | -50.36%39.4M | -47.89%47.78M | -71.07%33.52M |
Free cash flow | 23.62%748.33M | 13.56%236.3M | 7.55%197.25M | 58.50%233.69M | 22.06%81.08M | -1.50%605.34M | 7.12%208.07M | -0.04%183.4M | -9.85%147.44M | -9.35%66.43M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |